Načítá se...
Single vs. combination immunotherapeutic strategies for glioma
INTRODUCTION: Malignant gliomas are highly invasive tumors, associated with a dismal survival rate despite standard of care, which includes surgical resection, radiotherapy and chemotherapy with temozolomide (TMZ). Precision immunotherapies or combinations of immunotherapies that target unique tumor...
Uloženo v:
| Vydáno v: | Expert Opin Biol Ther |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5451096/ https://ncbi.nlm.nih.gov/pubmed/28286975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1305353 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|